Reducing Drug Shortages: A Legislative Push for Domestic Production
To address these issues, Senators Elizabeth Warren (D-MA) and Tina Smith (D-MN) have reintroduced the Pharmaceutical Supply Chain Defense and Enhancement Act. This legislation, first introduced in 2020, aims to reduce drug shortages, bolster national security, and decrease the U.S.’s reliance on foreign pharmaceutical manufacturers. Key Provisions of the Act The legislation focuses on creating a robust and secure pharmaceutical supply chain by introducing three primary measures: Identifying Critical Drugs: The FDA and the Department of Defense (DoD) will collaborate to compile a list of medications essential for public health and national security. This initiative ensures prioritized production and stockpiling of vital drugs. Funding Domestic Manufacturing: The bill allocates $1 billion annually to the Biomedical Advanced Research and Development Authority (BARDA) over the next five years. This funding is intended to boos...